Gene therapy has emerged as a novel strategy to modulate MMPs’ expression in gliomas, particularly by using gene silencing techniques such as RNA interference (RNAi) to knock down MMP-2 or MMP-9 expression. The gene discussed is MMP9; the disease is central nervous system cancer.